Key result
The incidence of infective endocarditis at 1 year after TAVI was 0.50%, and the risk increased with the use of orotracheal intubation (HR 3.87) and a self-expandable valve system (HR 3.12).
Why the study?
What are the incidence, predictors, and clinical outcomes of infective endocarditis following transcatheter aortic valve implantation?
Population
7944 patients who underwent transcatheter aortic valve implantation, including 53 patients who developed…
Design
Cohort
Follow-up
mean 1.1±1.2 years
Authors
Loading...
IE remains rare post-TAVI but was associated with intubation and self-expandable valves; hypothesis-generating for prevention strategies.
Cohort (n=7,944)
Yes
What are the incidence, predictors, and clinical outcomes of infective endocarditis following transcatheter aortic valve implantation?
Infective endocarditis after TAVI is a rare (0.50% at 1 year) but highly lethal complication, with increased risk associated with orotracheal intubation and the use of self-expandable valve systems.
Amat‐Santos et al. (2015) conducted a cohort in Infective endocarditis after TAVI (n=7,944). Transcatheter aortic valve implantation (TAVI) was evaluated on Infective endocarditis. The incidence of infective endocarditis at 1 year after TAVI was 0.50%, and the risk increased with the use of orotracheal intubation (HR 3.87) and a self-expandable valve system (HR 3.12).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: